Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyanoacrylates for skin closure.

William H Eaglstein1, Tory Sullivan

  • 1Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, FL 33136, USA.

Dermatologic Clinics
|April 20, 2005
PubMed
Summary

Cyanoacrylates (CAs) are increasingly used in medicine, with longer-chain versions like octyl-2-cyanoacrylate (2-OCA) showing improved safety and efficacy for wound repair and treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Irreproducibility of Preclinical Studies: Implications for Dermatologists and Dermatologic Investigators.

The Journal of investigative dermatology·2023
Same author

Efficacy and safety of a novel topical minocycline foam for the treatment of moderate to severe acne vulgaris: A phase 3 study.

Journal of the American Academy of Dermatology·2019
Same author

Real-world evidence-What is it and does it matter for approval of drugs?

Journal of the American Academy of Dermatology·2018
Same author

Identification and content validation of wound therapy clinical endpoints relevant to clinical practice and patient values for FDA approval. Part 1. Survey of the wound care community.

Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society·2017
Same author

End points in dermatologic clinical trials: A review for clinicians.

Journal of the American Academy of Dermatology·2016
Same author

Innovative New Drugs for Serious Nonlethal Diseases: The Cost to Develop and the Cost to Buy.

JAMA dermatology·2015

Area of Science:

  • Dermatology
  • Wound Healing
  • Medical Adhesives

Background:

  • Short-chain cyanoacrylates (CAs) faced adoption hurdles due to tissue toxicity concerns.
  • Medium-chain CAs, like butyl-cyanoacrylate, have a long history of safe use in Europe and Canada.
  • Longer-chain CAs, particularly octyl-2-cyanoacrylate (2-OCA), are now gaining widespread acceptance.

Purpose of the Study:

  • To review the evolving use of cyanoacrylates in cutaneous medicine.
  • To highlight the improved safety profile of newer CA formulations.
  • To discuss applications in wound closure and treatment.

Main Methods:

  • Review of literature on cyanoacrylate applications in dermatology.
  • Analysis of historical and current usage patterns of CAs.
  • Discussion of clinical evidence supporting 2-OCA efficacy and safety.

Main Results:

  • Octyl-2-cyanoacrylate (2-OCA) has gained FDA approval for various uses.
  • 2-OCA demonstrates reduced tissue toxicity compared to earlier CA formulations.
  • CAs are effective for laceration repair and as dressings for abrasions and wounds.

Conclusions:

  • Octyl-2-cyanoacrylate (2-OCA) represents a significant advancement in medical adhesives.
  • The use of CAs in cutaneous medicine is expected to expand further.
  • CAs offer a safe and effective alternative for wound management.

Related Experiment Videos